KRT19 and neoplasm: Notably, the tumor/myofibroblast ratio (CK19+/α-SMA+) was maintained (Fig. 7g), which together with reduced tumor aggressiveness (Fig. 7d, f) suggests that Ent treatment avoids the detrimental effects associated with near-complete stromal fibroblast depletion19,20.